Publications

Find at Harvard

Read Now

October 2022
Case

Afrigen Biologics: Vaccines for the Global South

By: Debora L. Spar and Julia Comeau

The majority of vaccines used on the continent of Africa (99%) are produced offshore. This makes African nations reliant on the West for major health care needs, a problem which was exacerbated by the COVID-19 pandemic. Afrigen Biologics (in partnership with the WHO)... View Details

Keywords: Vaccination; Vaccine; mRNA; COVID; COVID-19; Inequity; Hub-and-spoke; Health Care and Treatment; Health Pandemics; Production; Social Issues; Business and Government Relations; South Africa; Africa

David Moss is the Paul Whiton Cherington Professor at Harvard Business School, where he teaches in the Business, Government, and the International Economy (BGIE) unit. He earned his B.A. from Cornell University and his Ph.D. from Yale. In 1992-1993, he served as a... View Details

Keywords: health care; health care; health care; health care; health care; health care; health care

March 2023
Case

Between Two Minds: The Staglin Family

By: Lauren Cohen, Ronnie Stangler and Grace Headinger

Garen Staglin, Founder and Chairman of One Mind, reflected on his life’s work in brain health. As he contemplated stepping down in the next few years, he weighed how to pass along this legacy to his son, Brandon Staglin, the impetus behind and next generation of the... View Details

Keywords: Nonprofit Organizations; Well-being; Management Succession; Family Ownership; Mission and Purpose; Health Industry

23 Mar 2003
Research & Ideas

AIDS in Africa—What’s the Solution?

$10 behind health care, there's a problem." Dr. Pride Chigwedere, an Oak Foundation Research Fellow at the Harvard AIDS Institute who worked as a physician in Zimbabwe, said the policy issues begin with difficulties designing View Details

Keywords: by Julie Jette

07 Jun 2016
First Look

June 7, 2016

strategic, financial, and operational objectives. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=51110 May 2016 Oncology How the Affordable Care Act Has Affected Cancer Care in the United... View Details

Keywords: Sean Silverthorne

September 2002
Case

Align Technology, Inc.: Matching Manufacturing Capacity to Sales Demand

By: H. Kent Bowen and Jonathan P Groberg

Align Technology is a four-year-old medical products company that has invented a new product requiring new manufacturing processes. Demand for the new product has grown more slowly than initial forecasts predicted, and the cost structure is preventing the company from... View Details

Keywords: Health Care and Treatment; Collaborative Innovation and Invention; Problems and Challenges; Product; Forecasting and Prediction; Marketing Strategy; Sales; Demand and Consumers; Production; Health Industry

Web

Faculty & Research

an early-withdrawal penalty of 1 . When households have heterogeneous present bias, the social optimum is well approximated by a two-account system: (i) an account that is completely liquid and (ii) an account that is completely illiquid until retirement. Health View Details

January 2011 (Revised April 2014)
Case

Uptake of Malaria Rapid Diagnostic Tests

By: Nava Ashraf, Natalie Kindred and Richard Sedlmayr

This case describes barriers to adoption of malaria rapid diagnostic tests in Zambia and highlights the importance of understanding end users in promoting product adoption. Rapid diagnostic tests (RDTs) are simple, easy-to-use tools that provide a relatively reliable,... View Details

Keywords: Developing Countries and Economies; Health Pandemics; Technology; Health Care and Treatment; Policy; Behavior; Prejudice and Bias; Health Industry; Zambia

September 2022
Article

Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities

By: Leemore Dafny, Christopher Ody and Teresa Rokos

The federal Anti-Kickback Statute prohibits biopharmaceutical manufacturers from directly covering Medicare enrollees’ out-of-pocket spending for the drugs they manufacture, but manufacturers may donate to independent patient assistance charities and earmark donations... View Details

Keywords: Cost Sharing; Prescription Drugs; Drug Spending; Medicare; Dual Eligibility; Cost; Health Care and Treatment; Philanthropy and Charitable Giving; Pharmaceutical Industry

Find at Harvard

Register to Read

2010
Working Paper

Evaluating the Effects of Large-Scale Health Interventions in Developing Countries: The Zambian Malaria Initiative

By: Nava Ashraf, Gunther Fink and David N. Weil

Since 2003, Zambia has been engaged in a large-scale, centrally coordinated national anti-malaria campaign which has become a model in sub-Saharan Africa. This paper aims at quantifying the individual and macro level benefits of this campaign, which involved mass... View Details

Keywords: Cost vs Benefits; Developing Countries and Economies; Health Care and Treatment; Health Disorders; Performance Evaluation; Programs; Health Industry; Zambia

Read Now

April 2009 (Revised January 2015)
Case

Dr. Benjamin Hooks and Children's Health Forum

By: Rosabeth Moss Kanter, Charles J. Ogletree Jr, Howard Koh, Abbye Atkinson, Carmel Salhi and Aldo Sesia

"Dr. Benjamin Hooks and Children's Health Forum" charts the many different career paths of Hooks, a civil rights activist and pioneer. Hooks' positions ranged from lawyer, judge, preacher, entrepreneur to the first African American commissioner of the Federal... View Details

Keywords: Decision Choices and Conditions; Health Care and Treatment; Leadership; Corporate Social Responsibility and Impact; Personal Development and Career; Nonprofit Organizations; Social Issues

18 Apr 2022
HBS Case

Dick’s Sporting Goods Followed Its Conscience on Guns—and It Paid Off

our economic analysis.” Crafting a careful communications strategy Stack and his colleagues fully expected a backlash from angry customers and gun-rights groups, such as the National Rifle Association, and they were additionally concerned... View Details

Keywords: by Jay Fitzgerald

January 2014 (Revised April 2025)
Supplement

The PGA Tour (B)

By: Ramon Casadesus-Masanell and Cole Magrath

In 1994, the PGA Tour (the "Tour"), the dominant incumbent professional golf circuit, had created tremendous value for its players. In the 1974 season, players competed for $8 million in prize money; by the 1994 season, the total prize purse had increased to $56... View Details

Keywords: PGA Tour; Tim Finchem; Deane Beman; Golf; Professional Golf; Business Model; Value Creation; Adaptation; Sports; Business Strategy; Sports Industry; United States

December 2013 (Revised April 2025)
Case

The PGA Tour (A)

By: Ramon Casadesus-Masanell and Cole Magrath

In 1994, the PGA Tour (the "Tour"), the dominant incumbent professional golf circuit, had created tremendous value for its players. In the 1974 season, players competed for $8 million in prize money; by the 1994 season, the total prize purse had increased to $56... View Details

Keywords: PGA Tour; Tim Finchem; Deane Beman; Golf; Professional Golf; Business Model; Value Creation; Competition; Adaptation; Monopoly; Globalization; Sports; Business Strategy; Sports Industry; United States